The effect of acute and chronic lithium on forskolin-induced reduction of rat activity
- 1 August 1997
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 104 (8-9) , 943-952
- https://doi.org/10.1007/bf01285562
Abstract
Forskolin is a diterpene derivative that activates adenylate cyclase and raises cAMP levels in the cell. Both i.p. and i.c.v. forskolin cause behavioral hypoactivity. Lithium has been reported for many years to block cAMP accumulation, but the behavioral relevance of this biochemical effect is not clear. We studied the effect of acute and chronic lithium on icv forskolin-induced hypoactivity. Acute lithium had no effect, but chronic lithium significantly blocked forskolin-induced hypoactivity. The effect of chronic lithium occurred with both forskolin in DMSO and with a water-soluble forskolin derivative. These results suggest that this behavioral model can be used to investigate whether new inhibitors of adenylate cyclase possess lithium-like effects.Keywords
This publication has 40 references indexed in Scilit:
- A preliminary study of possible psychoactive effects of intravenous forskolin in depressed and schizophrenic patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
- Effects of Chronic Lithium Treatment on Agonist‐Enhanced Extracellular Concentrations of Cyclic AMP in the Dorsal Hippocampus of Freely Moving RatsJournal of Neurochemistry, 1995
- Adenylyl cyclases and the interaction between calcium and cAMP signallingNature, 1995
- The 4-dedimethylamino derivative of tetracycline loses both ability to block cyclic AMP accumulation and ability to inhibit rat motor activityEuropean Neuropsychopharmacology, 1994
- Lithiumin situDecreases Extracellular Levels of Cyclic AMP in the Dorsal Hippocampus of Living RatsBasic & Clinical Pharmacology & Toxicology, 1994
- Dysbalance of neuronal second messenger function in the aetiology of affective disorders: A pathophysiological concept hypothesising defects beyond first messenger receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Lack of effectiveness of forskolin or inositol as antidote in lithium toxicityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Behavioral and receptor binding studies of phencyclidine (PCP) and lithium interaction in the ratLife Sciences, 1986
- Interstrain correlation between behavioural effects of lithium and effects on cortical cyclic AMPPharmacology Biochemistry and Behavior, 1986
- Depressant effect of forskolin on spontaneous locomotor activity in miceGeneral Pharmacology: The Vascular System, 1985